Evolent Health, Inc. EVH
Evolent Health, Inc. statistics & valuation
Market cap$619.8M
P / S0.3×
P / B1.5×
Net margin-28.5%
Return on equity-128.7%
Net debt$818.7M
Enterprise value USD$1.4B
Earnings yield EBIT/EV-28.5%
Return on capital-27.1%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -21.9% | -1.6% | -3.6% | 0.3% | -4.7% | -28.4% | -36.5% | -7.6% | -16.7% | -93.4% |
| Net margin | -28.5% | -2.4% | -5.8% | -1.4% | -4.1% | -36.1% | -35.7% | -8.4% | -13.9% | -62.8% |
| FCF margin | — | — | — | — | — | — | -9.2% | -9.6% | -12.8% | -20.1% |
| Return on assets | -28.1% | -2.4% | -4.2% | -1.1% | -2.6% | -24.4% | -20.2% | -3.1% | -4.6% | -13.3% |
| Return on equity | -128.7% | -6.2% | -10.6% | -2.2% | -5.4% | -53.9% | -32.5% | -4.4% | -5.8% | -17.5% |
| Debt / equity | 2.34× | 0.49× | 0.56× | 0.48× | 0.31× | 0.43× | 0.32× | 0.19× | 0.12× | 0.13× |
| Current ratio | 1.31 | 0.85 | 1.01 | 1.10 | 1.18 | 1.36 | 1.19 | 1.81 | 2.85 | 2.01 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.